Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Virus vaccines: proteins prefer prolines
Rogier W. Sanders, John P. Moore
Cell Host & Microbe (2021) Vol. 29, Iss. 3, pp. 327-333
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

SARS-CoV-2 Variants, Vaccines, and Host Immunity
Priyal Mistry, Fatima Barmania, Juanita Mellet, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 275
Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
Karin Bok, Sandra Sitar, Barney S. Graham, et al.
Immunity (2021) Vol. 54, Iss. 8, pp. 1636-1651
Open Access | Times Cited: 230
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
Barton F. Haynes, Kevin Wiehe, Persephone Borrow, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 142-158
Open Access | Times Cited: 211
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants
Satoshi Ikegame, Mohammed Nure Alam Siddiquey, Chuan-Tien Hung, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 110
Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study
Marit J. van Gils, A. H. Ayesha Lavell, Karlijn van der Straten, et al.
PLoS Medicine (2022) Vol. 19, Iss. 5, pp. e1003991-e1003991
Open Access | Times Cited: 93
COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge
Anthony DiPiazza, Sarah R. Leist, Olubukola M. Abiona, et al.
Immunity (2021) Vol. 54, Iss. 8, pp. 1869-1882.e6
Open Access | Times Cited: 87
SARS-CoV-2 spike opening dynamics and energetics reveal the individual roles of glycans and their collective impact
Yui Tik Pang, Atanu Acharya, Diane L. Lynch, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 59
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
Mathieu Claireaux, Tom G. Caniels, Marlon de Gast, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 57
Principles of SARS-CoV-2 glycosylation
Himanshi Chawla, Elisa Fadda, Max Crispin
Current Opinion in Structural Biology (2022) Vol. 75, pp. 102402-102402
Open Access | Times Cited: 39
The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2
Joel D. Allen, Dylan P. Ivory, Ge Song, et al.
Cell Reports (2023) Vol. 42, Iss. 4, pp. 112307-112307
Open Access | Times Cited: 22
High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spike
Timothy J.C. Tan, Zongjun Mou, Ruipeng Lei, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Vaccinomics: a future avenue for vaccine development against emerging pathogens
José de la Fuente, Marinela Contreras
Expert Review of Vaccines (2021) Vol. 20, Iss. 12, pp. 1561-1569
Closed Access | Times Cited: 42
Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate
Kwinten Sliepen, Laura Radić, Joan Capella-Pujol, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 30
Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadth
Katrina M. Pollock, Hannah M. Cheeseman, Leon R. McFarlane, et al.
EBioMedicine (2025) Vol. 112, pp. 105544-105544
Open Access
Structure of endogenous Pfs230:Pfs48/45 in complex with potent malaria transmission-blocking antibodies
Ezra T. Bekkering, Randy Yoo, Sophia Hailemariam, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Structure-guided design of a prefusion GPC trimer induces neutralizing responses against LASV
Shaoyan Wang, Ruihua Li, Xiaoyan Pan, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Protein engineering strategies for rational immunogen design
Timothy M. Caradonna, Aaron G. Schmidt
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 39
Structure‐guided envelope trimer design in HIV‐1 vaccine development: a narrative review
Ronald Derking, Rogier W. Sanders
Journal of the International AIDS Society (2021) Vol. 24, Iss. S7
Open Access | Times Cited: 32
Probing the biophysical constraints of SARS-CoV-2 spike N-terminal domain using deep mutational scanning
Wenhao O. Ouyang, Timothy J.C. Tan, Ruipeng Lei, et al.
Science Advances (2022) Vol. 8, Iss. 47
Open Access | Times Cited: 26
Pro108Ser mutation of SARS-CoV-2 3CLpro reduces the enzyme activity and ameliorates the clinical severity of COVID-19
Kodai Abe, Yasuaki Kabe, Susumu Uchiyama, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 25
Mutational fitness landscape of human influenza H3N2 neuraminidase
Ruipeng Lei, Andrea Hernandez Garcia, Timothy J.C. Tan, et al.
Cell Reports (2023) Vol. 42, Iss. 1, pp. 111951-111951
Open Access | Times Cited: 14
A spike virosome vaccine induces pan-sarbecovirus antibody responses in mice
Mitch Brinkkemper, Meliawati Poniman, Esther Siteur-van Rijnstra, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109719-109719
Open Access | Times Cited: 4
High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimers
Iván del Moral-Sánchez, Rebecca A. Russell, Edith E. Schermer, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 21
A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion core
Rui Shi, Jiawei Zeng, Ling Xu, et al.
EBioMedicine (2022) Vol. 85, pp. 104297-104297
Open Access | Times Cited: 21
Structural dynamics reveal isolate-specific differences at neutralization epitopes on HIV Env
Edgar A. Hodge, Gajendra S. Naika, Sally Kephart, et al.
iScience (2022) Vol. 25, Iss. 6, pp. 104449-104449
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top